Trials / Conditions / Non Alcoholic Fatty Liver

Non Alcoholic Fatty Liver

30 registered clinical trials studyying Non Alcoholic Fatty Liver — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial NCT06138821	Pichamol Jirapinyo, MD, MPH	N/A
Recruiting	Identification of Liver Fibrosis Biomarkers NCT06819917	Roche Diagnostics GmbH	—
Recruiting	Walking Program in Fatty Liver Children With Phenylketonuria NCT06718842	Cairo University	N/A
Recruiting	Free Walking Exercise in Obstructive Sleep Apnea Patients With Non-alcoholic Fatty Liver NCT06508190	Ahram Canadian University	N/A
Completed	Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women W NCT06377631	Fundació Eurecat	N/A
Completed	Ultrasound and Attenuation Imaging NCT06552377	Hywel Dda Health Board	—
Withdrawn	Assessment of Fatty Liver With Thermo-acoustic Device NCT04302051	Medical College of Wisconsin	—
Unknown	Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease. NCT05822622	Sohag University	—
Completed	Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in NCT07338331	Galala University	N/A
Completed	Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) NCT05804422	Bogomolets National Medical University	N/A
Completed	Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced NCT05485714	United Arab Emirates University	—
Unknown	Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAF NCT05523024	Poznan University of Medical Sciences	N/A
Completed	Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH NCT05357248	Better Therapeutics	N/A
Completed	Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management NCT04823676	AB Biotics, SA	N/A
Unknown	Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods. NCT04553796	Assiut University	—
Unknown	Combi-elastography Assessment of Chronic Liver Disease Multi-center Study NCT04625166	Chinese PLA General Hospital	—
Unknown	Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease NCT06176079	Michael Ohliger, MD PhD	—
Completed	Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (P NCT04198805	Naga P. Chalasani	Phase 2
Enrolling By Invitation	Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia NCT04209816	Marja-Riitta Taskinen	—
Terminated	Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty L NCT03953456	Genfit	Phase 2
Unknown	Hepaxa Management of Non-alcoholic Fatty Liver Disease NCT03801577	BASF AS	N/A
Unknown	Oral Dietary Fucoxanthin Rich Supplement for Liver Health NCT03625284	Algatechnologies Ltd.	N/A
Completed	Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery NCT03849729	Hospital Juarez de Mexico	Phase 4
Recruiting	European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) NCT04190849	Cambridge University Hospitals NHS Foundation Trust	—
Completed	The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease NCT03222206	Korea University Guro Hospital	Phase 4
Completed	Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease) NCT03186859	University of Oxford	N/A
Completed	Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease NCT03738358	Samsung Medical Center	N/A
Completed	Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients NCT02923804	Pronova BioPharma	N/A
Completed	Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome NCT01787591	Ohio State University	N/A
Completed	The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholi NCT02030977	Dr Azita Hekmatdoost	Phase 2 / Phase 3